Retatrutide + Tirzepatide

100% delivery

  • Done Satisfaction Guaranteed
  • Done No Hassle Refunds
  • Done Secure Payments
GUARANTEED SAFE CHECKOUT
  • Visa Card
  • MasterCard
SKU: retatrutide-tirzepatide Category:

Description

For Research Use Only. Not for Human or Veterinary Use.
Weight Management20mg*10vialsHPLC ≥ 99%COA per batch

Retatrutide + Tirzepatide

TT20 · Retatrutide 10mg · Tirzepatide 10mg · Retatrutide · LY3437943 · Tirzepatide · LY3298176

Specifications:
Click to preview COA & reports online View all COA
Retatrutide  + Tirzepatide
TL;DR

TT20 is a research peptide set containing Retatrutide 10 mg and Tirzepatide 10 mg, two synthetic 39-amino-acid peptides designed for comparative studies of GIP, GLP-1, and glucagon receptor signaling, peptide structure, and analytical characterization.

Overview

TT20 combines Retatrutide 10 mg and Tirzepatide 10 mg in one comparative research set for laboratory studies involving engineered peptide structures, receptor pharmacology, and metabolic signaling pathways.

Molecular Composition and Research Profile

TT20 contains two structurally defined synthetic peptides: Retatrutide and Tirzepatide. Each compound is a 39-amino-acid peptide with lipid-associated structural modifications and a lyophilized presentation for laboratory research. Retatrutide is identified by CAS No. 2381089-83-2 and has the molecular formula C221H342N46O68, with a reported molecular weight of approximately 4731.33 g/mol. Its research profile includes activity at the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor. Tirzepatide is identified by CAS No. 2023788-19-2 and has the molecular formula C225H348N48O68, with a reported molecular weight of approximately 4813.45 g/mol. It is described as a synthetic peptide associated with dual GIP and GLP-1 receptor activity. The TT20 format allows researchers to examine two related but distinct peptide designs within comparative laboratory workflows, including analytical identification, peptide characterization, receptor-signaling studies, and structure-activity research. This product is supplied for laboratory research use only and is not intended for human or veterinary use.

Key Highlights

  • Two Peptide Research Compounds in One Set
  • Distinct Receptor Research Profiles
  • Synthetic 39-Amino-Acid Peptides
  • Defined Chemical Identification

Safety & Side Effects

TT20 is a research peptide set containing Retatrutide 10 mg and Tirzepatide 10 mg, two synthetic 39-amino-acid peptides designed for comparative studies of GIP, GLP-1, and glucagon receptor signaling, peptide structure, and analytical characterization. When used in research, Retatrutide + Tirzepatide should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.

Published retatrutide + tirzepatide side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for metabolic regulation and energy expenditure readouts and any off-target effects relevant to the compound’s mechanism when designing a study.

For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.

Dosage & Protocol

There is no standardized human dosage for Retatrutide + Tirzepatide; it is supplied strictly for laboratory research. Reported retatrutide + tirzepatide dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.

Research protocols typically document retatrutide + tirzepatide dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 2023788-19-2 (Tirzepatide) / 2381089-83-2 (Retatrutide), molecular formula C225H348N48O68 (Tirzepatide) / C221H342N46O68 (Retatrutide), molecular weight 4813.45 g/mol (Tirzepatide) / 4731.33 g/mol (Retatrutide)). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.

Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.

How to Order

1

Enquiry

Send product code, strength and quantity for a fast quote.

2

Quotation

Receive price, lead time and specification.

3

QC & COA

Batch tested by HPLC/LC-MS; COA issued.

4

Delivery

Discreet, tracked worldwide shipping.

Specifications

Product nameRetatrutide + Tirzepatide
Product codeTT20
Specification20mg*10vials
CAS number2023788-19-2 (Tirzepatide) / 2381089-83-2 (Retatrutide)
Molecular formulaC225H348N48O68 (Tirzepatide) / C221H342N46O68 (Retatrutide)
Molecular weight4813.45 g/mol (Tirzepatide) / 4731.33 g/mol (Retatrutide)
Purity≥99%(subject to batch COA)

Applications

ResearchLaboratoryAcademicDrug Discovery

Packaging & Shipping

Available pack sizes

20mg*10vials

Shipping

WorldwideCold ChainExpress

Storage & Handling

Store the unopened lyophilized vials at 2–8°C for routine storage. For long-term storage, keep the sealed vials at or below -20°C, protected from light and moisture. Under these conditions, the recommended shelf life is up to 24 months from the manufacturing date when stored in the original sealed container, subject to the applicable batch COA and retest date. Before opening, allow the vial to reach room temperature while it remains sealed to minimize condensation. After reconstitution, store the solution at 2–8°C and use within 7 days. For longer preservation after reconstitution, aliquot the solution and store at or below -20°C for up to 30 days. Avoid repeated freeze-thaw cycles, prolonged exposure to room temperature, direct light, and vigorous shaking. TT20 contains two separate lyophilized research peptides: Retatrutide 10 mg and Tirzepatide 10 mg. Storage conditions apply to each sealed vial. For laboratory research use only. Not intended for human or veterinary use.